Prolonged exposure therapy for PTSD among spinal cord injury survivors: Study protocol for a randomized controlled trial

Contemporary Clinical Trials Communications

Jamie R. Pogue¹  Michael Foreman²  Megan Douglas²  Seema Sikka³  Kiara Leonard³  Sarita Patel⁴  Emily Carl⁴  Monica Bennett⁴  Ann Marie Warren⁴  Nicholas E. Curcio⁴  Emma Turner⁴  Estrella V. Thomas⁴  Simon Driver⁴  Andrea Wierzchowski⁴  Maris Adams⁴  Mark B. Powers⁴  Katherine Froehlich-Grobe⁵ 

[1] Corresponding author. Baylor University Medical Center, 3409 Worth Street Tower, Suite C2.500, Dallas, TX, 75246, United States.;White Health, Dallas, TX, United States;;Baylor Institute of Rehabilitation, Baylor Scott &Baylor University Medical Center, Dallas, TX, United States;The University of Texas at Austin, Austin, TX, United States;

关键词: Spinal cord injury;    PTSD;    Prolonged exposure therapy;    Randomized controlled trial;   

DOI  :  

来源: DOAJ

【 摘 要 】

The National Spinal Cord Injury Statistical Center estimates 294,000 people in the US live with a spinal cord injury (SCI), with approximately 17,810 new cases each year. Although the physical outcomes associated with SCI have been widely studied, the psychological consequences of sustaining a SCI remain largely unexplored. Scant research has focused on posttraumatic stress disorder (PTSD) in this population, despite prevalence estimates suggesting that up to 60% of individuals with SCI experience PTSD post-injury, compared to only 7% of the general US population. Fortunately, prolonged exposure therapy (PE) is a well-researched and highly effective treatment for PTSD. However, no trauma focused exposure-based therapy for PTSD (e.g. PE) has not yet been tested in a SCI population. Thus, we aim to conduct the first test of an evidence-based intervention for PTSD among patients with SCI. Adults with SCI and PTSD (N = 60) will be randomly assigned to either: (1) 12-sessions of PE (2–3 sessions per week) or (2) a treatment as usual (TAU) control group who will receive the standard inpatient rehabilitation care for SCI patients. Primary outcomes will be assessed at 0, 6, 10, and 32 weeks.

【 授权许可】

Unknown